Prophylaxis in rare coagulation disorders -- factor XIII deficiency

Thrombosis Research
Diane Nugent

Abstract

Factor XIII (FXIII) deficiency is a very rare form of haemophilia resulting in different manifestations of bleeding disorders, but characterised by umbilical stump bleeding in up to 80% of patients. Although originally described as the final enzyme in the clotting cascade, FXIII is now recognised to play a role throughout the clotting process. Treatment with FXIII concentrate (Fibrogammin P, ZLB Behring) results in the re-establishment of a normal clotting pattern. Prophylaxis studies in France and the USA have demonstrated an excellent response following monthly prophylaxis with this plasma-derived, pasteurised concentrate. Patients with FXIII deficiency have good control of bleeding, with no development of inhibitors, or viral seroconversion. The development of registries such as that in the USA will enable the different manifestations of the disease to be explored.

Associated Clinical Trials

References

Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·V C YeeD C Teller

❮ Previous
Next ❯

Citations

Apr 4, 2008·Pharmacogenomics·Judith Maria LeitnerBernd Jilma
Sep 4, 2012·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Kiran KiniPushpa G Kini
Apr 3, 2012·Annales Françaises D'anesthèsie Et De Rèanimation·A El KoraichiS E El Kettani
Oct 19, 2010·Clinical Neurology and Neurosurgery·David L PerezKevin Sheth
May 2, 2015·Haemophilia : the Official Journal of the World Federation of Hemophilia·A IchinoseUNKNOWN Japanese Collaborative Research Group (JCRG) on AH13 (supported by the Japanese Ministry of Health, Labor, and Welfare)
Jun 23, 2009·Transfusion Medicine Reviews·Jeannie L CallumYulia Lin
Aug 7, 2007·Lancet·Nigel S Key, Claude Negrier
Apr 25, 2007·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·R DiehlC Berger
Feb 6, 2015·Thrombosis and Haemostasis·Gerhard DickneiteMarco Matucci Cerinic
Aug 21, 2009·Journal of Veterinary Emergency and Critical Care·Stephanie A Smith
Apr 13, 2011·Journal of Thrombosis and Haemostasis : JTH·M DreyfusUNKNOWN Groupe d'Etudes Francophone du FXIII
Mar 21, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·M NaderiM Karimi
Apr 24, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·R KesselD Manwani
Nov 13, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·T Todd, D J Perry
Dec 3, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·D J NugentA Mangione
Nov 8, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·C AshleyD J Nugent
Jun 3, 2008·The Journal of Emergency Medicine·Murat VuralMetin Ant Atasoy
Jan 10, 2014·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Jodie E OdameVicky R Breakey
May 24, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·M P GuzmanT Harrington
Jan 15, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·L Hsieh, D Nugent
May 5, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·S M SiboniF Peyvandi
Dec 3, 2014·Anaesthesia·P K Mensah, R Gooding
Nov 13, 2014·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Deniz TugcuZafer Baslar
Jul 14, 2017·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Ines MaaloulMongia Hachicha
Jun 21, 2013·Expert Review of Hematology·Brian M Elliott, Louis M Aledort
Dec 19, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·J LusherD Nugent
Dec 30, 2020·BMJ Case Reports·Papa DasariLaxmi Prasanna Gadipudi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Related Papers

Haemophilia : the Official Journal of the World Federation of Hemophilia
L Hsieh, Diane Nugent
The American Journal of Pediatric Hematology/oncology
S L AbbondanzoR A McPherson
© 2022 Meta ULC. All rights reserved